Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 525

1.

Idiopathic Post-Prandial Diarrhea Responsive to Anti-histamines.

Hassoun Y, Stevenson MR, Bernstein DI.

Ann Allergy Asthma Immunol. 2019 Jul 3. pii: S1081-1206(19)30494-6. doi: 10.1016/j.anai.2019.06.022. [Epub ahead of print] No abstract available.

PMID:
31279076
2.

Therapeutic HSV-2 vaccine decreases recurrent virus shedding and recurrent genital herpes disease.

Bernstein DI, Flechtner JB, McNeil LK, Heineman T, Oliphant T, Tasker S, Wald A, Hetherington S; Genocea study group.

Vaccine. 2019 Jun 6;37(26):3443-3450. doi: 10.1016/j.vaccine.2019.05.009. Epub 2019 May 15.

PMID:
31103365
3.

Usability of mepolizumab single-use prefilled syringe for patient self-administration.

Bel EH, Bernstein DI, Bjermer L, Follows R, Bentley JH, Pouliquen I, Bradford E.

J Asthma. 2019 Apr 24:1-10. doi: 10.1080/02770903.2019.1604745. [Epub ahead of print]

PMID:
31017022
4.

Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials.

Bernstein DI, Cardin RD, Pullum DA, Bravo FJ, Kousoulas KG, Dixon DA.

PLoS One. 2019 Mar 27;14(3):e0213401. doi: 10.1371/journal.pone.0213401. eCollection 2019.

5.

Understanding differences in allergen immunotherapy products and practices in North America and Europe.

Mahler V, Esch RE, Kleine-Tebbe J, Lavery WJ, Plunkett G, Vieths S, Bernstein DI.

J Allergy Clin Immunol. 2019 Mar;143(3):813-828. doi: 10.1016/j.jaci.2019.01.024. Review.

PMID:
30850069
6.

Identification of two early life eczema and non-eczema phenotypes with high risk for asthma development.

Johansson E, Biagini Myers JM, Martin LJ, He H, Ryan P, LeMasters GK, Bernstein DI, Lockey J, Khurana Hershey GK.

Clin Exp Allergy. 2019 Jun;49(6):829-837. doi: 10.1111/cea.13379. Epub 2019 Mar 27.

PMID:
30830718
7.

The Effects of Air Pollution on the Development of Atopic Disease.

Hassoun Y, James C, Bernstein DI.

Clin Rev Allergy Immunol. 2019 Feb 26. doi: 10.1007/s12016-019-08730-3. [Epub ahead of print] Review.

PMID:
30806950
8.

AAAAI/ACAAI Subcutaneous Immunotherapy Surveillance Study (2013-2017): Fatalities, Infections, Delayed Reactions, and Use of Epinephrine Autoinjectors.

Epstein TG, Liss GM, Berendts KM, Bernstein DI.

J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):1996-2003.e1. doi: 10.1016/j.jaip.2019.01.058. Epub 2019 Feb 15.

PMID:
30776526
9.

Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women.

Spinner C, Ding L, Bernstein DI, Brown DR, Franco EL, Covert C, Kahn JA.

Pediatrics. 2019 Feb;143(2). pii: e20181902. doi: 10.1542/peds.2018-1902. Epub 2019 Jan 22.

PMID:
30670582
10.

Factors Associated With Rotavirus Vaccine Coverage.

Aliabadi N, Wikswo ME, Tate JE, Cortese MM, Szilagyi PG, Staat MA, Weinberg GA, Halasa NB, Boom JA, Selvarangan R, Englund JA, Azimi PH, Klein EJ, Moffatt ME, Harrison CJ, Sahni LC, Stewart LS, Bernstein DI, Parashar UD, Payne DC.

Pediatrics. 2019 Feb;143(2). pii: e20181824. doi: 10.1542/peds.2018-1824. Epub 2019 Jan 17.

PMID:
30655333
11.

Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction.

Covert C, Ding L, Brown D, Franco EL, Bernstein DI, Kahn JA.

Hum Vaccin Immunother. 2019 Jan 11:1-8. doi: 10.1080/21645515.2018.1564438. [Epub ahead of print]

PMID:
30633598
12.

Mupirocin for Staphylococcus aureus Decolonization of Infants in Neonatal Intensive Care Units.

Kotloff KL, Shirley DT, Creech CB, Frey SE, Harrison CJ, Staat M, Anderson EJ, Dulkerian S, Thomsen IP, Al-Hosni M, Pahud BA, Bernstein DI, Yi J, Petrikin JE, Haberman B, Stephens K, Stephens I, Oler RE Jr, Conrad TM.

Pediatrics. 2019 Jan;143(1). pii: e20181565. doi: 10.1542/peds.2018-1565.

PMID:
30587533
13.

A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.

Bernstein DI, Pasetti MF, Brady R, Buskirk AD, Wahid R, Dickey M, Cohen M, Baughman H, El-Khorazaty J, Maier N, Sztein MB, Baqar S, Bourgeois AL.

Vaccine. 2019 Jan 21;37(4):602-611. doi: 10.1016/j.vaccine.2018.12.011. Epub 2018 Dec 15.

PMID:
30563789
14.

A Pediatric Asthma Risk Score to better predict asthma development in young children.

Biagini Myers JM, Schauberger E, He H, Martin LJ, Kroner J, Hill GM, Ryan PH, LeMasters GK, Bernstein DI, Lockey JE, Arshad SH, Kurukulaaratchy R, Khurana Hershey GK.

J Allergy Clin Immunol. 2019 May;143(5):1803-1810.e2. doi: 10.1016/j.jaci.2018.09.037. Epub 2018 Dec 13.

PMID:
30554722
15.

The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes.

Bernstein DI, Pullum DA, Cardin RD, Bravo FJ, Dixon DA, Kousoulas KG.

Vaccine. 2019 Jan 3;37(1):61-68. doi: 10.1016/j.vaccine.2018.11.042. Epub 2018 Nov 22.

PMID:
30471955
16.

DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.

Houser KV, Yamshchikov GV, Bellamy AR, May J, Enama ME, Sarwar U, Larkin B, Bailer RT, Koup R, Paskel M, Subbarao K, Anderson E, Bernstein DI, Creech B, Keyserling H, Spearman P, Wright PF, Graham BS, Ledgerwood JE; VRC 702 study team.

PLoS One. 2018 Nov 2;13(11):e0206837. doi: 10.1371/journal.pone.0206837. eCollection 2018.

17.

Authors' response.

Dao A, Bernstein DI.

Ann Allergy Asthma Immunol. 2018 Oct;121(4):513. doi: 10.1016/j.anai.2018.08.013. No abstract available.

PMID:
30290896
18.

Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction.

Chandler E, Ding L, Gorbach P, Franco EL, Brown DA, Widdice LE, Bernstein DI, Kahn JA.

J Adolesc Health. 2018 Jul;63(1):43-49. doi: 10.1016/j.jadohealth.2018.01.005.

19.

Author Response to Letter: Will increasing dosing intervals decrease the loss of anti-HPV seropositivity over time?

Widdice LE, Bernstein DI.

Vaccine. 2018 Aug 9;36(33):4967. doi: 10.1016/j.vaccine.2018.03.089. No abstract available.

PMID:
30033075
20.

Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital Herpes Simplex Virus-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled Trial.

Van Wagoner N, Fife K, Leone PA, Bernstein DI, Warren T, Panther L, Novak RM, Beigi R, Kriesel J, Tyring S, Koltun W, Lucksinger G, Morris A, Zhang B, McNeil LK, Tasker S, Hetherington S, Wald A.

J Infect Dis. 2018 Nov 5;218(12):1890-1899. doi: 10.1093/infdis/jiy415.

PMID:
29982727

Supplemental Content

Loading ...
Support Center